Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sankar D Navaneethan

Showing results (41-50 of 281) with videos related to

Pageof 29
Sort By:
Kidney Medicine|July 5, 2022
Moving Beyond Tools and Building Bridges: Lessons Learned From a CKD Decision Support in Primary CarePriya Joshi, Sankar D Navaneethan, Michelle M Estrella
Current Opinion in Nephrology and Hypertension|June 16, 2026
Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitorsMelanie Wanigatunga, Michael W Holliday, Sankar D Navaneethan
JAMA|November 7, 2025
Time for Broader Adoption of SGLT2 Inhibitors in Clinical Practice?L Parker Gregg, Biykem Bozkurt, Sankar D Navaneethan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2016
Phosphate Binders: The Evidence Gap PersistsMedha Airy, Wolfgang C Winkelmayer, Sankar D Navaneethan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 15, 2018
Estimated GFR Decline and Tubular Injury Biomarkers With Intensive Blood Pressure ControlCarl P Walther, Maulin Shah, Sankar D Navaneethan
Current Opinion in Nephrology and Hypertension|October 19, 2017
Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney diseaseCarl P Walther, Aravind Chandra, Sankar D Navaneethan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2007
Prevalence and predictors of lack of permanent vascular access in early referralsSankar D Navaneethan, Vinodh Jeevanantham, Sagar U Nigwekar
Current Opinion in Nephrology and Hypertension|June 20, 2024
Therapeutic approaches for pulmonary hypertension in patients with chronic kidney diseaseMarcelle Tuttle, Mark J Sarnak, Sankar D Navaneethan
Current Opinion in Nephrology and Hypertension|February 27, 2024
Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progressionMichael W Holliday, Livia Frost, Sankar D Navaneethan
Current Opinion in Nephrology and Hypertension|July 24, 2020
Editorial: Management of cardiovascular risk factors and other comorbidities in chronic kidney diseaseSehrish Ali, Muhammad S Ajmal, Sankar D Navaneethan
Pageof 29

Showing results (41-50 of 281) with videos related to

Sort By:
Pageof 29
Kidney Medicine|July 5, 2022
Moving Beyond Tools and Building Bridges: Lessons Learned From a CKD Decision Support in Primary CarePriya Joshi, Sankar D Navaneethan, Michelle M Estrella
Current Opinion in Nephrology and Hypertension|June 16, 2026
Primary prevention of chronic kidney disease in type 2 diabetes mellitus with sodium-glucose cotransporter 2 inhibitorsMelanie Wanigatunga, Michael W Holliday, Sankar D Navaneethan
JAMA|November 7, 2025
Time for Broader Adoption of SGLT2 Inhibitors in Clinical Practice?L Parker Gregg, Biykem Bozkurt, Sankar D Navaneethan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 25, 2016
Phosphate Binders: The Evidence Gap PersistsMedha Airy, Wolfgang C Winkelmayer, Sankar D Navaneethan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 15, 2018
Estimated GFR Decline and Tubular Injury Biomarkers With Intensive Blood Pressure ControlCarl P Walther, Maulin Shah, Sankar D Navaneethan
Current Opinion in Nephrology and Hypertension|October 19, 2017
Blood pressure parameters and morbid and mortal outcomes in nondialysis-dependent chronic kidney diseaseCarl P Walther, Aravind Chandra, Sankar D Navaneethan
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 29, 2007
Prevalence and predictors of lack of permanent vascular access in early referralsSankar D Navaneethan, Vinodh Jeevanantham, Sagar U Nigwekar
Current Opinion in Nephrology and Hypertension|June 20, 2024
Therapeutic approaches for pulmonary hypertension in patients with chronic kidney diseaseMarcelle Tuttle, Mark J Sarnak, Sankar D Navaneethan
Current Opinion in Nephrology and Hypertension|February 27, 2024
Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progressionMichael W Holliday, Livia Frost, Sankar D Navaneethan
Current Opinion in Nephrology and Hypertension|July 24, 2020
Editorial: Management of cardiovascular risk factors and other comorbidities in chronic kidney diseaseSehrish Ali, Muhammad S Ajmal, Sankar D Navaneethan
Pageof 29